Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost–utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study) - Concepedia

Concepedia

Publication | Open Access

Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost–utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study)

DOI Full Paper Access

14

Citations

47

References

2022

Year

Ariadna Colomer‐Carbonell, Juan P. Sanabria‐Mazo, Halbert Hernández-Negrín, Xavier Borràs, Carlos Suso‐Ribera, Azucena García‐Palacios, Jordi Muchart, Josep Munuera, Francesco D’Amico, Michaël Maes,

Abstract

NCT04739995.

References

	Year	Citations

Page 1